Intended laboratory context
Illustrative applications
- Analytical comparison
- Method development
- In-vitro laboratory investigation
- Research protocol development
Lyophilized Peptides
Ipamorelin 10MG
NNC 26-0161; Aib-His-D-2-Nal-D-Phe-Lys-NH2
A synthetic pentapeptide growth-hormone secretagogue studied as an agonist of growth-hormone secretagogue receptor 1a.
CatalogIPA-PW-10MG
ManufacturerRemetide
PurityTarget ≥99% by RP-HPLC; lot result controls
Pack10 mg
$65.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
6296 in stock
For laboratory research use only. Not for human or veterinary use.
Ipamorelin 10MG$65.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
12 approved certificates are attached to this product record.
Technical information
Chemical & material record
Presented in a scientific-catalog format so the material can be evaluated by identity, form and documentation before purchase.
- Identity
- Ipamorelin research peptide; salt form controlled by the approved specification
- Synonyms
- NNC 26-0161; Aib-His-D-2-Nal-D-Phe-Lys-NH2
- CAS number
- See approved salt-form specification
- Molecular formula
- See approved Remetide material specification
- Formula weight
- See approved Remetide material specification
- Sequence / identity note
- Aib-His-D-2-Nal-D-Phe-Lys-NH2; salt form controlled in the technical record
- Manufacturer
- Remetide
- Manufacturing role
- Custom peptide synthesis and manufacture
- Form
- Lyophilized, non-sterile research material
- Purity specification
- Target ≥99% by RP-HPLC; lot result controls
- Storage
- -20°C, dry and protected from light; follow lot documentation
- Pack size
- 10 mg
- Catalog number
- IPA-PW-10MG
Product description
Published context, clearly separated from lot claims.
A technical catalog should make the chemical record, relevant experimental literature and product-specific documentation independently reviewable.
Ipamorelin (NNC 26-0161) is a synthetic pentapeptide growth-hormone secretagogue. Published receptor studies characterize binding and signaling at growth-hormone secretagogue receptor 1a (GHS-R1a), along with growth-hormone release in primary rat pituitary cells.
Reported values include a Ki of 63.4 nM in GHS-R1a-expressing COS-7 cells, an IP3-accumulation EC50 of 46.9 nM in receptor-expressing BHK cells and a growth-hormone-release EC50 of 1.3 nM in primary rat pituitary cells. Assay design and material form can affect observed values.
Selected published findings
- Bound GHS-R1a in a receptor-expressing COS-7 cellular system.
- Induced IP3 accumulation in GHS-R1a-expressing BHK cells.
- Induced growth-hormone release in primary rat pituitary cells.
References and product citations 2
- Hansen, B.S., Raun, K., Nielsen, K.K., et al. Pharmacological characterisation of a new oral GH secretagogue, ipamorelin. European Journal of Endocrinology 141(2), 180–189 (1999).
- Raun, K., Hansen, B.S., Johansen, N.L., et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology 139(5), 552–561 (1998).
Literature interpretation: This summary describes published experimental literature and is not a lot specification, clinical claim, use instruction or representation that the supplied research material will reproduce a published result. This record intentionally excludes dosing, administration, clinical outcomes, patient eligibility and therapeutic comparisons.
Documentation package
Documentation
- PDFCertificate of AnalysisSample
- PDFHPLC chromatogramSample
- PDFMass-spectrometry summarySample
- PDFHandling statementSample
For laboratory research workflows only. Not for administration to humans or animals and not supplied with dosing or reconstitution guidance.
Need a current record?
Documentation before decision-making.
Reference IPA-PW-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model